BALPHARMA

Bal Pharma LimitedNSE
₹89.26-1.41 (-1.56%)

Market Closed · NSE · INR

Open

₹91

High

₹91.5

Low

₹88.2

Prev Close

₹90.67

52-Week Range72% from low
₹60.42
₹100.5

Market Cap

₹144.35 Cr

Small Cap

P/E (TTM)

22.9

EPS

₹3.96

Div Yield

1.32%

P/B Ratio

1.73

ROE

7.7%

Key Metrics

Forward P/E-
Book Value₹51.66
Debt/Equity1.94×
Revenue Growth2.7%
Profit Margin4.29%
Operating Margin10.24%
Volume1.04 L
Avg Volume (20d)59.7 K
Delivery %61.65%
Trades1,759

What If I Had Invested?

Chart data not available for this range

AI Analysis

Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.

AI Technical Analysis

Buy/sell zones with live web research

Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.

Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.

About

HealthcareDrug Manufacturers - Specialty & Generic

Bal Pharma Limited, together with its subsidiaries, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk drugs. It also pr...

balpharma.com986 employees

Technical Indicators

Loading sector benchmark…

Quality scores

Valuation bands

Intrinsic value calculators

Peer Comparison

Dividend History

Recent: 1.20/share
22
23
24
25
18 Sept 20251.20
17 Sept 20241.20
18 Sept 20231.00
13 Sept 20221.00
Loading events…

Recent Filings (NSE)

Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.

Institutional Deals(NSE)

Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.

Governance Scorecard

AlphaView composite

Fund Actions

Loading fund activity…

News

News sourced from RSS feeds. Headlines link to original articles.

Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.